MDGeneticPro BRCA1 & BRCA2

Discover the Hereditary Risk for Breast Cancer.

Combating Breast Cancer. Together.

According to the National Breast Cancer Foundation, 1 in 8 women will develop breast cancer in her lifetime. On average, every 2 minutes a women is diagnosed with breast cancer in the US. These statistics continue to be alarming, but hereditary breast cancer screening can help detect the risk for both women and men.

With a simple blood draw, our advanced BRCA gene mutation testing identifies harmful variants in the BRCA1 or BRCA2 genes. We offer quick turnaround times with results in just 15 days.

Discover the risk. Live with confidence.

    In 2022, an
    estimated 287,500 new cases of invasive breast cancer will be diagnosed in women in the U.S according to the National Breast Cancer Foundation.
    The National Breast Cancer Foundation estimates 2,710 men will be diagnosed with breast cancer in US.

    Let’s Talk

    We want to hear from you! Tell us more about your interest in MDChemistryPro today.

    [gravityform id="65" description="false" ajax="true"]

    Read Our Blog

    Breast Cancer Awareness Month

    Breast Cancer Awareness Month

    Breast cancer is the second most common cancer among women in the U.S. This year, an estimated 290,000 new cases of invasive breast cancer will be diagnosed in women. Although this is an alarming number, breast cancer is a highly treatable disease, and early detection...

    read more